Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study
Author(s) -
Mathieu Coeman,
Yannick van Durme,
F Bauters,
Ellen Deschepper,
Ingel Demedts,
Peter Smeets,
Guy Joos,
Guy Brusselle
Publication year - 2011
Publication title -
therapeutic advances in respiratory disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.022
H-Index - 37
eISSN - 1753-4666
pISSN - 1753-4658
DOI - 10.1177/1753465811406771
Subject(s) - medicine , bronchiectasis , retrospective cohort study , asthma , pulmonary function testing , logistic regression , diffuse panbronchiolitis , observational study , lung , erythromycin , microbiology and biotechnology , biology , antibiotics
Previous studies have demonstrated that long-term low-dose macrolides are efficacious in cystic fibrosis (CF) and diffuse panbronchiolitis, two chronic neutrophilic airway diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom